The A1 subunit of Cholera toxin as an adjuvant for HIV DNA vaccines

被引：0
|
作者：
Bagley, Kenneth
机构：
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2009年 / 51卷
关键词：
D O I：
10.1097/01.qai.0000351171.41220.f3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
215
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [41] Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant
    Maeyama, J
    Isaka, M
    Yasuda, Y
    Matano, K
    Kozuka, S
    Taniguchi, T
    Ohkuma, K
    Tochikubo, K
    Goto, N
    MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (02) : 111 - 117
  • [42] Adjuvant effects of cholera toxin b subunit on immune response to recombinant thyrotropin receptor in mice
    Fan, JL
    Peterson, JW
    Prabhakar, BS
    JOURNAL OF AUTOIMMUNITY, 2000, 14 (01) : 43 - 52
  • [43] Recombinant cholera toxin B subunit activates murine dendritic cells in vitro and in vivo as an adjuvant
    Isomura, I
    Morita, A
    Yasuda, Y
    Isaka, M
    Tochikubo, K
    Tsuji, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 580 - 580
  • [44] Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant
    Goto, N
    Maeyama, J
    Yasuda, Y
    Isaka, M
    Matano, K
    Kozuka, S
    Taniguchi, T
    Miura, Y
    Ohkuma, K
    Tochikubo, K
    VACCINE, 2000, 18 (20) : 2164 - 2171
  • [45] SYNERGISTIC ACTION OF CHOLERA-TOXIN B SUBUNIT (AND ESCHERICHIA-COLI HEAT-LABILE TOXIN-B SUBUNIT) AND A TRACE AMOUNT OF CHOLERA WHOLE TOXIN AS AN ADJUVANT FOR NASAL INFLUENZA VACCINE
    TAMURA, S
    YAMANAKA, A
    SHIMOHARA, M
    TOMITA, T
    KOMASE, K
    TSUDA, Y
    SUZUKI, Y
    NAGAMINE, T
    KAWAHARA, K
    DANBARA, H
    AIZAWA, C
    OYA, A
    KURATA, T
    VACCINE, 1994, 12 (05) : 419 - 426
  • [46] Antigen-Independent Restriction of Pneumococcal Density by Mucosal Adjuvant Cholera Toxin Subunit B
    Kuipers, Kirsten
    Diavatopoulos, Dimitri A.
    van Opzeeland, Fred
    Simonetti, Elles
    van den Kieboom, Corne H.
    Kerstholt, Mariska
    Borczyk, Malgorzata
    van IngenSchenau, D.
    Brandsma, Eelke T.
    Netea, Mihai G.
    de Jonge, Marien I.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (10): : 1588 - 1596
  • [47] ADJUVANT FORMULATIONS ENHANCE HUMORAL AND CELL-MEDIATED RESPONSES TO HIV-1 SUBUNIT VACCINES
    RUHADZE, E
    MCNICHOLL, JM
    BOND, KB
    OLSON, MR
    KWAN, BW
    TAKAYAMA, KK
    MCDOUGAL, JS
    HUNTER, RL
    FASEB JOURNAL, 1995, 9 (03): : A208 - A208
  • [48] COMPARATIVE EFFECTIVENESS OF THE CHOLERA TOXIN-B SUBUNIT AND ALKALINE-PHOSPHATASE AS CARRIERS FOR ORAL VACCINES
    DERTZBAUGH, MT
    ELSON, CO
    INFECTION AND IMMUNITY, 1993, 61 (01) : 48 - 55
  • [49] Improved Purification Process for Cholera Toxin and its Application to the Quantification of Residual Toxin in Cholera Vaccines
    Jang, Hyun
    Kim, Hyo Seung
    Kim, Jeong Ah
    Se, Jin Ho
    Carbis, Rodney
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2009, 19 (01) : 108 - 112
  • [50] Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice
    Wu, JY
    Wade, WF
    Taylor, RK
    INFECTION AND IMMUNITY, 2001, 69 (12) : 7695 - 7702
12345